Company

EMBioSys

Medical Equipment Manufacturing 4 employees

Employees: 4
Contacts: 3
Emails: 3
Phones: 2

www.embiosys.com LinkedIn

EMBioSys Overview

Website: www.embiosys.com
Industry: Medical Equipment Manufacturing
Employees: 4
Founded: 2022
NAICS: Medical Equipment and Supplies Manufacturing

Surgical and Medical Instrument Manufacturing

Surgical Appliance and Supplies Manufacturing

Keywords

Providence

About EMBioSys

EMBioSys is developing a platform technology of therapeutic non-pharmacological, electrode-free wearable garments that deliver iEF Therapy (low level induced electric fields) to improve patient outcomes for treatment of breast cancer. The market entry product will target triple-negative breast cancer (TNBC), which accounts for 40% of all breast cancer mortality. iEF Therapy inhibits cancer metastasis, shrinks the primary tumor, improves efficacy of standard of care chemotherapy, and boosts the natural immune response while selectively targeting only cancer cells. This novel technology offers physicians a low risk, easily tolerated therapy to potentiate the standard of care for treatment of solid tumors, starting with breast cancer.

EMBioSys Contact Details

People in AeroLeads: 3
With contact data: 3
Email contacts: 3; 100.0% coverage
Phone contacts: 2; 66.7% coverage

EMBioSys Org Chart

Sample employees and titles

Name	Title	Location	Contact
Chris Barron	Co-founder and CEO at Embiosys	Greater Boston, United States	Email Phone
Richard (Rick) Clemon, Cpa, Cgma	Partner, Clemon Consulting	Norfolk, Massachusetts, United States	Email Phone
Vish Subramaniam	Academy Professor and Professor	Toronto, Ontario, Canada	Email